Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tauroursodeoxycholic acid for dissolution of gallbladder cholesterol stones
ChiCTR1900020504Phase 4Recruiting
- Sponsor
- Union Hospital of Huazhong University of Science and Technology
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tauroursodeoxycholic acid in cholelithiasis (2 arms), sponsored by Union Hospital of Huazhong University of Science and Technology. Primary endpoint: Prominent rate and effective rate after 24 weeks treatment for gallstone dissolution. Started Apr 2017; status: recruiting.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on ChiCTR1900020504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020504.